Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jabs

Showing results (361-370 of 367) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 367 results.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Ocular Immunology and Inflammation|December 11, 2019
Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) WorkshopRupesh Agrawal, Aniruddha Agarwal, Douglas A Jabs, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Ocular Immunology and Inflammation|April 7, 2020
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting ProceedingsRupesh Agrawal, Ilaria Testi, Sarakshi Mahajan, et al.
Pageof 37

Showing results (361-370 of 367) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 367 results.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Ocular Immunology and Inflammation|December 11, 2019
Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) WorkshopRupesh Agrawal, Aniruddha Agarwal, Douglas A Jabs, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Ocular Immunology and Inflammation|April 7, 2020
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting ProceedingsRupesh Agrawal, Ilaria Testi, Sarakshi Mahajan, et al.
Pageof 37